CooperCompanies Announces Release Date for Second Quarter 2024

Rhea-AI Impact

(Low)

Rhea-AI Sentiment

(Neutral)

Rhea-AI Summary

CooperCompanies will release its second quarter 2024 financial results on May 30, 2024, at 4:15 PM ET. A conference call to discuss the results and corporate developments will follow at 5:00 PM ET. Investors can access the call via dial-in number 800-715-9871 and conference ID 1712676. An audio webcast and replay will be available at http://investor.coopercos.com.

04/30/2024 - 04:15 PM

SAN RAMON, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO) today announced it will report second quarter 2024 financial results on Thursday, May 30, 2024, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments.

The dial-in number for the call is 800-715-9871 and the conference ID is 1712676. A simultaneous audio webcast and subsequent replay can be accessed at http://investor.coopercos.com.

About CooperCompanies
CooperCompanies (Nasdaq: COO) is a leading global medical device company focused on improving lives one person at a time. The Company operates through two business units, CooperVision and CooperSurgical. CooperVision is a trusted leader in the contact lens industry, improving the vision of millions of people every day. CooperSurgical is a leading fertility and women’s health company dedicated to assisting women, babies and families at the healthcare moments that matter most. Headquartered in San Ramon, CA, CooperCompanies (“Cooper”) has a workforce of more than 15,000 with products sold in over 130 countries. For more information, please visit www.coopercos.com.

Contact:
Kim Duncan
Vice President, Investor Relations and Risk Management
925-460-3663
ir@cooperco.com